LFX is a cutting-edge solution that provides healthcare professionals with sophisticated tools to conduct high-quality lung assessments.

Oscillometry can detect small airway hyper-responsiveness, offering more information about the patient’s prognosis for asthma or COPD. It complements spirometry providing additional insights. By utilizing both tests, physicians can make more informed patient treatment decisions.

Learn about the latest updates in the 2022 GINA Asthma Guide, including asthma and COVID-19, diagnosis, management in LMICs, symptom control, treatment strategies, and more.